Filana Therapeutics, Inc. FLNA
Set alert
0.56 USD -0.06 -9.81%
At close · Nov 2
0.57 +0.01 +1.34%
After hours · Nov 2, 7:48 PM ET
0.56 Day range 0.63
0.56 52-week range 3.45
- YTD
- -71.67%
- 1 year
- -82.79%
- Open
- 0.63
- Prev close
- 0.622
- Mkt cap
- 27.10M
- Vol
- 546.58K
- Avg vol
- 2.02M
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.56
- High
- 0.63
1m chart
Built from the cached one-day intraday bars.
Signals (81)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:59 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 3:58 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 3:51 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 3:51 PM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 3:51 PM | 8 hours ago |
| MACD: Buy Signal | Nov 2, 3:50 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 3:48 PM | 8 hours ago |
| SMA: Bullish | Nov 2, 3:48 PM | 8 hours ago |
| SMA: Bearish | Nov 2, 3:32 PM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 3:19 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 3:07 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 2:48 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 2:46 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 2:44 PM | 9 hours ago |
| MACD: Buy Signal | Nov 2, 2:33 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 2:17 PM | 10 hours ago |
| MACD: Sell Signal | Nov 2, 1:42 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 1:37 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 1:37 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 1:31 PM | 10 hours ago |
Newest 20 of 81.
Financials — quick view
FLNA Revenue — quarterly 0
FLNA Net income — quarterly -8.60M
FLNA EPS — quarterly -0.18
News
- Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes
- Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
- Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
- Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
- FDA Lifts Clinical Hold Form Filana Therapeutics' Investigational New Drug Application To Initiate Planned Phase 2a Trial In Participants With Tuberous Sclerosis Complex-Related Epilepsy
Your note
Sign in to keep a note on FLNA — it syncs with the Stock Master app.